InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Kenney, Christopher John. Director active across 1 company, notably Xenon Pharmaceuticals Inc.. Aggregated, 2 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €264k. History available since 28 August 2026. The latest transaction was filed on 28 August 2026 (10 - Acquisition or disposition in the public market). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations